Fig. 1 · Structure

Documents & Downloads

Tasosartan

Cat. No. A10891 CAS 145733-36-4

Angiotensin II receptor antagonist

Tasosartan is an angiotensin II receptor antagonist.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

In Vitro Studies

Tasosartan was evaluated in an activity assay using SARS-CoV-2 nsp15, with nsp15 in DMSO as the control. Tasosartan reduced nsp15 activity, and increasing its concentration produced no further change in activity. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Tasosartan and nsp15 Activity

Cell-based study · SARS-CoV-2 nsp15 [1]

SARS-CoV-2 nsp15 was preincubated with Tasosartan in DMSO before activity quantification. Tasosartan reduced nsp15 activity, with similar activity observed at the higher concentration.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
Quantification of nsp15 activitynsp15 activity nsp15 retained only ~40% of its activity[1]

Literature-Reported Treatment Conditions

Treatment concentration
600 and 1000 µM
Exposure duration
7 min at room temperature
Method
previously incubated
Vehicle
DMSO
Methods and source locations

Compound reported in the paper: Tasosartan

Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.

2. Materials and Methods > 2.3. RNase Activity Assays (S38, S41, S42); 3. Results > 3.4. Searching for SARS-CoV-2 nsp15 Inhibitors (S171, S174, S177, S178, S181); Figure 7 legend (S233, S234)

Quantification of nsp15 activity: Quantification of nsp15 activity; comparator: nsp15 in the presence of DMSO — 3. Results > 3.4. Searching for SARS-CoV-2 nsp15 Inhibitors (S178, S181); Figure 7 legend (S233)

Specifications

Manufacturer Adooq Bioscience
Actions Antagonist
CAS Number 145733-36-4
Applications Angiotensin II receptor antagonist
Formula C23H21N7O
Molecular Weight 411.56
Synonyms ANA-756
SMILES
CC1=C2CCC(=O)N(C2=NC(=N1)C)CC3=CC=C(C=C3)C4=CC=CC=C4C5=NNN=N5

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Research References

  1. [1] Saramago M, Costa VG, Souza CS, et al. The nsp15 Nuclease as a Good Target to Combat SARS-CoV-2: Mechanism of Action and Its Inactivation with FDA-Approved Drugs. Microorganisms (2022). PMID: 35208797 DOI: 10.3390/microorganisms10020342 Source material

Added to your cart

View Cart Checkout
Loading...